Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


08 noviembre 2013

Conservative approach for type IA endoleaks may be feasible in selected patients

Vascular News

Frederico Bastos Gonçalves (Utrecht University Medical Center, Utrecht, The Netherlands) reported that, according to the results of a study, conservative management of primary type Ia endoleaks that occur after endovascular aortic aneurysm repair (EVAR) may be feasible in selected patients.

08 noviembre 2013

Excluder iliac branch endoprosthesis receives the CE mark

Vascular News

Gore has announced the Gore Excluder iliac branch endoprosthesis, the first complete, fully engineered system (Gore designed iliac branch and internal iliac components) intended for endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms, has received the CE mark.

07 noviembre 2013

Gore s Excluder Iliac Branch Endoprosthesis Approved in Europe

Endovascular Today

Gore & Associates (Flagstaff, AZ) announced European CE Mark approval for the Gore Excluder iliac branch endoprosthesis, which is intended for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms. Composed of Gore’s established technology platform with its expanded polytetrafluoroethylene graft, the Excluder iliac device is used in conjunction with Gore Excluder abdominal aortic aneurysm endoprosthesis components to isolate the common iliac artery from systemic blood flow and preserve blood flow in the external iliac and internal iliac arteries.

11 mayo 2013

El abordaje multidisciplinar del pie diabético permite reducir el número de amputaciones de extremidades inferiores

Noticias Médicas

El abordaje multidisciplinar del pie diabético permite reducir el número de amputaciones de extremidades inferiores • Éste es el propósito de un estudio desarrollado por el Hospital Torrecárdenas de Almería, primer centro hospitalario andaluz en implantar una consulta multidisciplinar, en la que trabajan de forma conjunta cirujanos vasculares y endocrinólogos

31 octubre 2013

Drug-eluting balloon revenue to more than double by 2019

Vascular News

The global sales of drug-eluting balloons across the 10 major markets are expected to witness a significant increase over the coming years, from US$164m in 2012 to US$477m in 2019, at a Compound Annual Growth Rate of 16%, following the product’s launch in the USA and Japanese markets, according to a new report from GlobalData.

31 octubre 2013

4EVER and PEACE Data Support Biotronik s Pulsar Stents to Treat SFA Disease

Endovascular Today

Biotronik (Lake Oswego, OR) announced the results from two independent clinical studies concerning the company’s Pulsar-18 self-expanding stent system in the treatment of superficial femoral artery (SFA) disease. The prospective, multicenter 4EVER study’s 24-month results were backed up by 12-month results from the multicenter, prospective PEACE registry. In both studies, the Pulsar stent’s efficacy data compared favorably with study results for other bare-metal stents, stated the company.

16 octubre 2013

Study Supports Chimney Stent Grafts to Treat Complex Aortic Aneurysms

Endovascular Today

In the International Society of Endovascular Specialists’ Journal of Endovascular Therapy, Mario Lachat, MD, et al published midterm results showing a high success rate using the chimney stent graft technique and its periscope variation to treat patients with complex aortic aneurysms (2013;20:597–605).

16 octubre 2013

Treating cutaneous ulcers with human skin wound dressings

Vascular News

Researchers from Universite Laval’s Faculty of Medicine and CHU de Quebec have shown that it is possible to treat venous ulcers unresponsive to conventional treatment with wound dressings made from human skin grown in vitro. A study published in the journal Advances in Skin and Wound Care demonstrates how this approach was successfully used to treat venous lower-extremity ulcers in patients who had been chronically suffering from such wounds.

15 octubre 2013

Screening can significantly reduce number of venous thromboembolism deaths

Vascular News

A UK national initiative to carry out mandatory screening of hospital patients for deep vein thrombosis has resulted in a “significant” reduction in death rates, experts in Birmingham have concluded. A major study was carried out involving every single patient admitted to all 163 National Health Service (NHS) hospital trusts in England between July 2010 and March 2012

15 octubre 2013

AccessClosure announces distribution agreement for the Flash Ostial System

Vascular News

AccessClosure announced on 8 October 2013 an exclusive agreement with Ostial Corporation to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The Flash Ostial System is designed to help overcome the challenges of aorto-ostial stenting and compliments the Mynx Product Family of Vascular Closure Devices to expand AccessClosure’s portfolio.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.